BIOGEMMA is formerly owned by Unigrains, through Unigrains Capital Investissement Direct, since 2016.

When did Unigrains acquire BIOGEMMA?

Unigrains acquired BIOGEMMA in 2016 and exited after 2 years.

Has BIOGEMMA been sold?

Yes. BIOGEMMA was exited in 2018 via MBO.

Healthcare·

France·Exited 2018·Held 2yr

BIOGEMMA is a healthcare company, headquartered in France.

Entry

2016

Hold

2yr

Exit

2018

Est. EV

–

Investor

HQFrance

SectorHealthcare

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Unigrains Capital Investissement Direct

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings